First Horizon Corp Catalent, Inc. Transaction History

First Horizon Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 24, 2025	SELL	N/A	-1,982 Closed	0 $0
Q1 2021 May 11, 2021	BUY	$101.51 - $125.27 $15,429 - $19,041	152 Added 8.31%	1,982 $208,000
Q4 2020 Feb 11, 2021	SELL	$85.88 - $105.36 $20,095 - $24,654	-234 Reduced 11.34%	1,830 $190,000
Q3 2020 Nov 12, 2020	BUY	$72.74 - $92.5 $150,135 - $190,920	2,064 New	2,064 $176,000

16.5M

10.7K

4.5K

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of First Horizon Corp, based on Form 13F filings with the SEC.

Stay updated on First Horizon Corp with notifications on news.